Literature DB >> 19145589

Psychological effects of prevention: do participants of a type 2 diabetes prevention program experience increased mental distress?

Katrin E Giel1, Paul Enck, Stephan Zipfel, Markus Schrauth, Anna Bury, Marjo Graf, Sabine Kümmerle, Martina Guthoff, Norbert Stefan, Hans-Ulrich Häring, Andreas Fritsche.   

Abstract

OBJECTIVE: To evaluate the mental health outcome of a lifestyle intervention for the prevention of type 2 diabetes and to exclude possible harmful psychological effects.
BACKGROUND: There is little empirical data on potential harmful effects of prevention programs. However, information, education, diagnostic procedures, phenotyping and risk assessment may cause or intensify psychological distress such as anxiety, depression or somatization in vulnerable individuals.
METHODS: The Tuebingen Lifestyle Intervention Program (TULIP) for the prevention of type 2 diabetes has assessed mental health outcome in the participants after 9 months of program participation using the Symptom Checklist-90-R (SCL-90-R). The 24-months lifestyle intervention TULIP comprises regular exercise and changes in nutrition and assesses both, a broad range of somatic parameters as well as psychometric variables. For an interim analysis of psychological outcome, complete data sets of the SCL-90-R assessed at baseline and after 9 months of intervention were available for 195 participants (125 females, 70 males; age: 46.1 +/- 10.6 years). Data on somatization, anxiety, depression and overall psychological distress were compared to baseline levels.
RESULTS: SCL-90-R scores of the TULIP-participants did not significantly differ from the German healthy reference population. Compared to baseline, a significant decrease in SCL-90-R scores was found for anxiety, depression and overall psychological distress at re-assessment after 9 months.
CONCLUSION: The interim analysis on mental health outcome of a type 2 diabetes prevention program comprising extensive phenotyping and risk assessment rules out adverse psychological effects, suggesting rather beneficial changes concerning symptoms of anxiety, depression and overall psychological distress. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19145589     DOI: 10.1002/dmrr.917

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  3 in total

Review 1.  Screening for Diabetes and Prediabetes.

Authors:  Daisy Duan; Andre P Kengne; Justin B Echouffo-Tcheugui
Journal:  Endocrinol Metab Clin North Am       Date:  2021-07-12       Impact factor: 4.748

2.  Perceived symptoms in people living with impaired glucose tolerance.

Authors:  Susanne Andersson; Inger Ekman; Ulf Lindblad; Febe Friberg
Journal:  Nurs Res Pract       Date:  2011-07-12

3.  The association between diabetes and depressive symptoms varies by quality of diabetes care across Europe.

Authors:  Eva A Graham; Katie H Thomson; Clare L Bambra
Journal:  Eur J Public Health       Date:  2018-10-01       Impact factor: 3.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.